
Mustang Bio, Inc.
USD0.62
-0.04 (-5.57%)
CEO
Manuel Litchman
IPO Date
2017-08-22
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.63
Prev. Close
$0.65
Day Low
$0.61
Day High
$0.63
52W Low
$0.53
52W High
$2.12
Market Cap
$0.00B
Volume
0.01M
Mustang Bio Announces Updated Interim Phase 1/2 Data for MB-106 CD20-Targeted CAR T in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia